$0.03
(Market cap
$1,171 Mln
Revenue (TTM)
$716 Mln
P/E Ratio
--
P/B Ratio
1.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.1 %
-
ROCE
-- %
-
Industry P/E
50.52
-
EV/EBITDA
17.2
-
Debt to Equity
0.1
-
Book Value
$--
-
EPS
$-1.5
-
Face value
--
-
Shares outstanding
46,824,793
10 Years Aggregate
CFO
$566.50 Mln
EBITDA
$813.20 Mln
Net Profit
$-300.70 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Avanos Medical (AVNS)
| 122.9 | 0.9 | 88.3 | 100.9 | -0.7 | -8.8 | -2.9 |
|
BSE Sensex*
| -12.5 | -4.2 | -4.5 | -10.2 | 5.8 | 7.4 | 10.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Avanos Medical (AVNS)
| -29.5 | -28.8 | -17.1 | -21.9 | -24.4 | 36.1 | -24.8 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Avanos Medical (AVNS)
|
25.0 | 1,170.6 | 715.9 | -69.4 | -8.1 | -8.9 | -- | 1.5 |
| 9.9 | 6,499.8 | 6,552.2 | -551.4 | -4.3 | -9.9 | -- | 1.1 | |
| 304.2 | 8,139.5 | 2,589.9 | 168.8 | 21.4 | 2.5 | 50.5 | 1.2 | |
| 57.2 | 8,584.0 | 3,458.5 | -11.6 | 2.6 | -0.6 | -- | 3.5 | |
| 24.6 | 3,721.6 | 2,808.1 | 67.7 | 6.8 | 2.2 | 55.8 | 1.2 | |
| 126.3 | 7,341.7 | 551.4 | -189.3 | -15.6 | -26.3 | -- | 9.0 | |
| 100.0 | 6,574.4 | 1,546.2 | 279.0 | 15.0 | 23.9 | 24.1 | 5.5 | |
| 180.0 | 9,364.6 | 1,558.5 | 76.3 | 19.6 | 9.5 | 44.3 | 11.9 | |
| 321.1 | 12,606.9 | 1,454.3 | 171.1 | 11.1 | 12.1 | 74 | 8.5 | |
| 130.1 | 6,899.2 | 763.3 | 51.4 | 11.7 | 2.5 | 134.4 | 3.3 |
Shareholding Pattern
View DetailsAbout Avanos Medical (AVNS)
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes,... Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; and Trident and Esentec RFA radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. Avanos Medical, Inc. was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. The company was incorporated in 2014 and is headquartered in Alpharetta, Georgia. Read more
-
CEO & Director
Mr. Joseph F. Woody
-
Interim CEO, Senior VP & Chief Transformation Officer
Mr. Michael C. Greiner CPA
-
Headquarters
Alpharetta, GA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Avanos Medical (AVNS)
What is the current share price of Avanos Medical Inc (AVNS) Today?
The share price of Avanos Medical Inc (AVNS) is $25.03 (NYSE) as of 09-Jun-2026 16:02 EDT. Avanos Medical Inc (AVNS) has given a return of -0.7% in the last 3 years.
What is the current PB & PE ratio of Avanos Medical Inc (AVNS)?
Since, TTM earnings of Avanos Medical Inc (AVNS) is negative, P/E ratio is not available.
The P/B ratio of Avanos Medical Inc (AVNS) is 1.50 times as on 05-Jun-2026, a 54 discount to its peers’ median range of 3.26 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-7.67
|
0.67
|
|
2024
|
-1.87
|
0.88
|
|
2023
|
-16.91
|
0.85
|
|
2022
|
25.18
|
0.98
|
|
2021
|
267.45
|
1.33
|
What is the 52 Week High and Low of Avanos Medical Inc (AVNS)?
The 52-week high and low of Avanos Medical Inc (AVNS) are Rs 25.49 and Rs 9.30 as of 10-Jun-2026.
What is the market cap of Avanos Medical Inc (AVNS)?
Avanos Medical Inc (AVNS) has a market capitalisation of $ 1,171 Mln as on 05-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Avanos Medical Inc (AVNS)?
Before investing in Avanos Medical Inc (AVNS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.